Present adress : Institut Pasteur , Departement International , Paris
Verified email at
Cited by
Cited by
Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients
M Ben-Ali, MR Barbouche, S Bousnina, A Chabbou, K Dellagi
Clinical and Vaccine Immunology 11 (3), 625-626, 2004
Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease
M Ben Ahmed, H Houman, M Miled, K Dellagi, H Louzir
Arthritis & Rheumatism: Official Journal of the American College of …, 2004
Immunologic Determinants of Disease Evolution in Localized Cutaneous Leishmaniasis due to Leishmania major
H Louzir, PC Melby, A Ben Salah, H Marrakchi, K Aoun, R Ben Ismail, ...
Journal of Infectious Diseases 177 (6), 1687-1695, 1998
Waldenstrom's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients
K Dellagi, P Dupouey, JC Brouet, A Billecocq, D Gomez, JP Clauvel, ...
Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a …
A Abdelkefi, S Ladeb, L Torjman, TB Othman, A Lakhal, NB Romdhane, ...
Blood, The Journal of the American Society of Hematology 111 (4), 1805-1810, 2008
Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis
IA Maalej, M Chenik, H Louzir, AB Salah, C Bahloul, F Amri, K Dellagi
The American journal of tropical medicine and hygiene 68 (3), 312-320, 2003
Human monoclonal IgM with autoantibody activity against intermediate filaments.
K Dellagi, JC Brouet, J Perreau, D Paulin
Proceedings of the National Academy of Sciences 79 (2), 446-450, 1982
Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice
S Abdelhak, H Louzir, J Timm, L Blel, Z Benlasfar, M Lagranderie, ...
Microbiology 141 (7), 1585-1592, 1995
Alteration of vimentin intermediate filament expression during differentiation of human hemopoietic cells.
K Dellagi, W Vainchenker, G Vinci, D Paulin, JC Brouet
The EMBO journal 2 (9), 1509-1514, 1983
A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.
H Zakraoui, A Zaatour, A Ftaiti, B Zaafouri, A Garraoui, PL Olliaro, ...
The American journal of tropical medicine and hygiene 53 (2), 162-166, 1995
Large-scale DNA fingerprinting of Mycobacterium tuberculosis strains as a tool for epidemiological studies of tuberculosis
D Chevrel-Dellagi, A Abderrahman, R Haltiti, H Koubaji, B Gicquel, ...
Journal of Clinical Microbiology 31 (9), 2446-2450, 1993
Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia
A Sassi, H Louzir, A Ben Salah, M Mokni, A Ben Osman, K Dellagi
Clinical & Experimental Immunology 116 (1), 127-132, 1999
Seroepidemiology of hepatitis B, C and delta viruses in Tunisia
H Triki, N Said, AB Salah, A Arrouji, FB Ahmed, A Bouguerra, S Hmida, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 91 (1), 11-14, 1997
Peripheral neuropathy associated with monoclonal IgM autoantibody
AJ Steck, N Murray, K Dellagi, JC Brouet, M Seligmann
Annals of neurology 22 (6), 764-767, 1987
Identification of a Disulfide Isomerase Protein of Leishmania major as a Putative Virulence Factor
YB Achour, M Chenik, H Louzir, K Dellagi
Infection and Immunity 70 (7), 3576-3585, 2002
Clinical and Genetic Heterogeneity of Inherited Autosomal Recessive Susceptibility to Disseminated Mycobacterium bovis Bacille Calmette-Guérin Infection
H Elloumi-Zghal, MR Barbouche, J Chemli, M Béjaoui, A Harbi, N Snoussi, ...
Journal of Infectious Diseases 185 (10), 1468-1475, 2002
MicroRNA Expression Profile in Human Macrophages in Response to Leishmania major Infection
J Lemaire, G Mkannez, FZ Guerfali, C Gustin, H Attia, RM Sghaier, ...
PLoS neglected tropical diseases 7 (10), e2478, 2013
Heterogeneity of Wild Leishmania major Isolates in Experimental Murine Pathogenicity and Specific Immune Response
C Kébaıer, H Louzir, M Chenik, AB Salah, K Dellagi
Infection and Immunity 69 (8), 4906-4915, 2001
WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind …
A Ben Salah, PA Buffet, G Morizot, N Ben Massoud, A Zaˆatour, ...
PLoS neglected tropical diseases 3 (5), e432, 2009
A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major
SBH Ahmed, C Bahloul, C Robbana, S Askri, K Dellagi
Vaccine 22 (13-14), 1631-1639, 2004
The system can't perform the operation now. Try again later.
Articles 1–20